Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD44 expression in rejecting rat small bowel allografts

C R Uff1, S D Reid, R F Wood

  • 1Department of Surgical Sciences, Northern General Hospital, Sheffield, United Kingdom.

Transplantation
|November 15, 1995
PubMed
Summary

This study shows that CD44 (a cell surface protein) is involved in intestinal transplant rejection. Increased CD44 expression on intestinal epithelium correlates with rejection, suggesting its role in graft failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National Alcohol Survey of households in Trinidad and Tobago (NASHTT): Alcohol use in households.

BMC public health·2017
Same author

Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.

Oncogene·2015
Same author

Anti-inflammatory effects of ischemic preconditioning on rat small bowel allografts.

Transplantation proceedings·2014
Same author

Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review.

British journal of cancer·2014
Same author

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.

British journal of cancer·2014
Same author

The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.

Cell death & disease·2014

Area of Science:

  • Immunology
  • Transplantation Biology
  • Gastroenterology

Background:

  • CD44 is a cell surface protein involved in cell adhesion and immune responses.
  • Its specific role in immune interactions and lymphocyte trafficking is not fully understood.
  • Investigating CD44 in intestinal transplantation could reveal insights into graft rejection mechanisms.

Purpose of the Study:

  • To investigate CD44 expression in intestinal tissue following heterotopic rat small bowel transplantation.
  • To assess the impact of transplantation on intestinal epithelial cell proliferation.
  • To explore the potential role of CD44 in the rejection process.

Main Methods:

  • Heterotopic rat small bowel transplantation (allograft and isograft models).
  • Blind grading of CD44 expression in lamina propria and intestinal epithelium.

Related Experiment Videos

  • Assessment of intestinal epithelial cell proliferation using Ki67 staining.

    • Main Results:

    • CD44 expression was high in the lamina propria of both allografted and isografted animals.
    • Villus epithelial CD44 expression was significantly higher in allografted animals and increased with rejection.
    • Ki67 positivity was also elevated in allografted animals, indicating increased proliferation.

    Conclusions:

    • CD44 expression on intestinal epithelium is not restricted to crypts during rejection.
    • CD44 appears to be involved in the intestinal transplant rejection process.
    • Changes in CD44 expression and epithelial proliferation offer potential targets for managing graft rejection.